21,551 results match your criteria: "Cardiac Calcifications"
J Surg Case Rep
November 2024
Cardiovascular and Thoracic Unit, Department of Surgery, Lampang Hospital, Lampang 52000, Thailand.
Circ Cardiovasc Imaging
December 2024
Division of Cardiology, Department of Medicine, Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (M.E.).
Background: Black adults show heightened cardiovascular risk compared with other groups despite comparable or lower coronary artery calcium (CAC) scores, indicating potential cardiovascular risk underestimation by CAC. Abdominal aortic calcification (AAC), preceding CAC, may predict cardiovascular events better in Black adults who are prone to early atherosclerotic cardiovascular disease and excess events at low CAC scores.
Methods: We included 2551 participants from the JHS (Jackson Heart Study) visit 2 examination (2005-2008) without cardiovascular disease, followed through 2016.
Echocardiography
December 2024
Clinic for Cardiology, Elisabeth Krankenhaus Essen, Essen, Germany.
Cardiooncology
November 2024
Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, 06511, USA.
Background: Clonal hematopoiesis of indeterminate potential (CHIP) has been shown to increase all-cause mortality and risk of cardiomyopathy in patients with solid malignancies. CHIP has also been shown to increase T cell activation in heart failure patients. It is unclear whether CHIP can affect the risk of immune checkpoint inhibitor (ICI) myocarditis in patients with cancer treated with immunotherapy.
View Article and Find Full Text PDFClin Biochem
November 2024
Department of Heart Disease, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway.
Eur Heart J Case Rep
November 2024
Department of Cardiology, Heart and Vascular Center, Rheinland Klinikum Neuss, Preussenstr 84, Neuss 41464, Germany.
Background: Advancement in interventional techniques has significantly improved the ability of percutaneous coronary intervention (PCI) to treat complex coronary artery disease. Despite these advancements, coronary artery calcification poses a substantial challenge during PCI, contributing to increased risks of procedural complications, prolonged procedure duration, and an increase in radiation exposure dose for both patients and physicians. Recently, robotic PCI has emerged, allowing physicians to remotely control and deliver wires and catheters, leading to a notable reduction of the operator radiation exposure and a decrease in the risk of operator physical injuries such as back pain.
View Article and Find Full Text PDFTurk J Pediatr
November 2024
Department of Cardiology, Hacettepe University Hospital, Ankara, Türkiye.
Background: Gaucher disease is a rare lysosomal storage disorder caused by glucocerebrosidase enzyme deficiency resulting in the cumulative deposition of glucocerebroside in macrophages, predominantly effecting bone marrow, liver and spleen. Gaucher disease type IIIC is a rare subtype that is characterized by cardiovascular involvement, eye-movement disorders, and late-onset neurological symptoms.
Case Presentation: We present a 14-year-old adolescent boy diagnosed with Gaucher disease type IIIC at age four with a homozygous D409H mutation who developed severe aortic valve stenosis, extensive aortic calcification and a porcelain aorta despite enzyme replacement treatment since the diagnosis.
Am J Case Rep
November 2024
Clinical Department of Cardiology, Interventional Electrocardiology and Hypertension, University Hospital, Cracow, Poland.
BACKGROUND Echogenic masses in the mitral annulus are often incidental findings during routine echocardiography examinations. Most represent the wide spectrum of underlying mitral annular calcifications and usually do not require further diagnostic workup. However, a rare variant called "caseous calcification of the mitral annulus" (CCMA) can be challenging to diagnose and often requires an extensive workup with the use of multiple imaging studies in order to accurately confirm the pathology.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
November 2024
Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
Background: Despite the excellent success and safety of intravascular lithotripsy (IVL) in heavily calcified lesions, evidence in acute coronary syndromes (ACS) remains limited.
Aims: This study aimed to evaluate the procedural and clinical outcomes of IVL in heavily calcified ACS.
Methods: Patients who underwent IVL between 2019 and 2024 from the ongoing prospective BENELUX registry were eligible for inclusion.
BMJ Open
November 2024
Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
Objectives: This study evaluated the association between serum albumin levels and coronary artery calcification (CAC) progression in asymptomatic adults without hypoalbuminaemia at baseline.
Design: Observational cohort study.
Setting: Data from the Korea Initiatives on Coronary Artery Calcification (KOICA) which is a retrospective, single ethnicity, multicentre and observational registry were analysed.
Echocardiography
November 2024
Faculty of Applied Healthcare Science, Deggendorf Institute of Technology, Deggendorf, Germany.
Int J Cardiovasc Imaging
November 2024
Department of Health, University of Bath, Bath, UK.
Rev Endocr Metab Disord
November 2024
Department of Cardiology of The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, China.
Mol Med
November 2024
Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital and Beijing Institute of Respiratory Medicine, Capital Medical University, Beijing, 100020, China.
Background: Vascular calcification is a crucial pathophysiological process associated with age-related cardiovascular diseases. Elabela, a recently identified peptide, has emerged as a significant player in the regulation of cardiovascular function and homeostasis. However, the effects and underlying mechanisms of Elabela on age-related vascular calcification remain largely unexplored.
View Article and Find Full Text PDFSci Rep
November 2024
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei-Cedars-Sinai Integrative Cardiovascular Imaging Research Center, Yonsei University College of Medicine, Yonsei University Health System, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, South Korea.
Data on hyperuricemia-related changes in coronary atherosclerosis are limited, especially in sex difference. This study evaluated the association between hyperuricemia and coronary artery calcification (CAC) progression in asymptomatic Korean men and women. We analysed the data of 12,316 asymptomatic adults (51.
View Article and Find Full Text PDFEur J Nutr
November 2024
Center for Clinical Research and Prevention, Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
Heart Rhythm
November 2024
Division of Cardiology, Clinical Cardiac Electrophysiology Section, Department of Medicine, Duke University Hospital, Durham, North Carolina. Electronic address:
J Diabetes Complications
January 2025
Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Japan.
Background: We aimed to examine the stepwise risk stratification for predicting major adverse cardiovascular events (MACE) in patients with DM and suspected coronary artery disease (CAD).
Method: 1187 patients with suspected CAD enrolled in a prospective cohort study were examined. The patients were evaluated step-by-step with coronary artery calcification (CAC), coronary artery stenosis (CAS), and FFR analysis.
Cardiovasc Diabetol
November 2024
Division of Cardiology, Yonsei Cardiovascular Center, Yonsei University Health System, Seoul, South Korea.
Background: Both insulin resistance and hyperglycemia are important risk factors for atherosclerosis. While the characteristics of atherosclerosis are obviously different according to established diabetes, little has been known regarding the risk of coronary artery calcification (CAC) progression related to the biomarkers of atherogenic index of plasma (AIP), triglyceride glucose (TyG) index, and hemoglobin A1C (HbA1C) in conditions with and without diabetes.
Methods: We analyzed 12,326 asymptomatic Korean adults (mean age 51.
US Cardiol
November 2023
Division of Cardiology, Providence St Peter Hospital Olympia, WA.
Complex percutaneous cardiac intervention (PCI) is a growing procedure in modern day cath labs. The treated population is often older, with multiple comorbidities, complex coronary anatomy, left ventricular dysfunction, and possibly concomitant valvular heart disease and/or cardiogenic shock. As such, PCI of bifurcations, chronic total occlusions, and atherectomy coronary interventions are becoming more common.
View Article and Find Full Text PDFRadiol Case Rep
January 2025
Cardiology Department, University Hospital Agadir, Medical School of Medicine & Pharmacy Ibn Zohr University, Agadir, Morocco.
Recanalized coronary thrombus is a rare and under-recognized condition in interventional practice, however its incidence is steadily increasing with the use of endo-coronary imaging. It has been initially described by pathological studies in approximately one-third of chronic coronary occlusions. It is described as a chronic occlusion that constitutes several endothelium-covered channels separated by septa that converge into a single lumen.
View Article and Find Full Text PDFOncologist
November 2024
Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
Background: Convergent data suggest that advanced prostate cancer and coronary heart disease (CHD) share biological vulnerabilities that may be linked to adiposity. Here we explore whether leptin, as a marker and mediator of adiposity, could link prostate cancer to CHD.
Methods: Patients with metastatic castration-resistant prostate cancer (mCRPC) enrolled in a phase II trial (NCT02703623) studying androgen deprivation therapy, abiraterone, prednisone, and apalutamide were eligible if they had plasma and a chest CT scan available.
Int J Cardiol
February 2025
Department of Medicine, Divisions of Cardiology and Geriatrics, and Department of Obstetrics & Gynecology and Women's Health, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, United States of America. Electronic address:
There are similarities in the pathophysiologic mechanisms of atherosclerosis, calcific aortic valve disease (CAVD) and mitral annular calcification (MAC), however, medical treatment to slow or stop the progression of CAVD or MAC has been more elusive as compared to atherosclerosis. Atherosclerosis and CAVD share common demographic, clinical, protein, and genetic factors even more so than with MAC, which supports the possibility of shared medical therapies, though abrogating calcific extracellular vesicle shedding could be a common target for all three conditions. Herein, we summarize the overlapping and distinct pathways for further investigation, as well as key areas where additional research is needed.
View Article and Find Full Text PDFHeart Vessels
November 2024
Department of Cardiology, Osaka Police Hospital, Osaka, Japan.